The Impact of a Comprehensive Risk Prediction Model for Colorectal Cancer on a Population Screening Program

被引:7
作者
Saya, Sibel [1 ,2 ]
Emery, Jon D. [1 ,2 ]
Dowty, James G. [3 ]
McIntosh, Jennifer G. [1 ,2 ]
Winship, Ingrid M. [4 ,5 ]
Jenkins, Mark A. [3 ]
机构
[1] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Gen Practice, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Fac Med Dent & Hlth Sci, Ctr Canc Res, Melbourne, Vic 3010, Australia
[3] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, Genom Med & Family Canc Clin, Melbourne, Vic, Australia
[5] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Med, Melbourne, Vic, Australia
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
GENOME-WIDE ASSOCIATION; SINGLE NUCLEOTIDE POLYMORPHISMS; POLYGENIC RISK; SUSCEPTIBILITY LOCI; GENERAL-PRACTICE; GENETIC RISK; BREAST; PREVENTION; GUIDELINES; WOMEN;
D O I
10.1093/jncics/pkaa062
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In many countries, population colorectal cancer (CRC) screening is based on age and family history, though more precise risk prediction could better target screening. We examined the impact of a CRC risk prediction model (incorporating age, sex, lifestyle, genomic, and family history factors) to target screening under several feasible screening scenarios. Methods: We estimated the model's predicted CRC risk distribution in the Australian population. Predicted CRC risks were categorized into screening recommendations under 3 proposed scenarios to compare with current recommendations: 1) highly tailored, 2) 3 risk categories, and 3) 4 sex-specific risk categories. Under each scenario, for 35- to 74-year-olds, we calculated the number of CRC screens by immunochemical fecal occult blood testing (iFOBT) and colonoscopy and the proportion of predicted CRCs over 10 years in each screening group. Results: Currently, 1.1% of 35- to 74-yearolds are recommended screening colonoscopy and 56.2% iFOBT, and 5.7% and 83.2% of CRCs over 10 years were predicted to occur in these groups, respectively. For the scenarios, 1) colonoscopy was recommended to 8.1% and iFOBT to 37.5%, with 36.1% and 50.1% of CRCs in each group; 2) colonoscopy was recommended to 2.4% and iFOBT to 56.0%, with 13.2% and 76.9% of cancers in each group; and 3) colonoscopy was recommended to 5.0% and iFOBT to 54.2%, with 24.5% and 66.5% of cancers in each group. Conclusions: A highly tailored CRC screening scenario results in many fewer screens but more cancers in those unscreened. Category-based scenarios may provide a good balance between number of screens and cancers detected and are simpler to implement.
引用
收藏
页数:7
相关论文
共 56 条
[1]  
[Anonymous], 2017, POP PROJ AUSTR
[2]   Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study [J].
Archer, Stephanie ;
de Villiers, Chantal Babb ;
Scheibl, Fiona ;
Carver, Tim ;
Hartley, Simon ;
Lee, Andrew ;
Cunningham, Alex P. ;
Easton, Douglas F. ;
McIntosh, Jennifer G. ;
Emery, Jon ;
Tischkowitz, Marc ;
Antoniou, Antonis C. ;
Walter, Fiona M. .
PLOS ONE, 2020, 15 (03)
[3]   Global patterns and trends in colorectal cancer incidence and mortality [J].
Arnold, Melina ;
Sierra, Monica S. ;
Laversanne, Mathieu ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin ;
Bray, Freddie .
GUT, 2017, 66 (04) :683-691
[4]  
Australian Institute of Health and Welfare, 2017, CANC SER, V103
[5]  
Australian Institute of Health and Welfare, 2016, AUSTR CANC INCIDENCE
[6]   GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project [J].
Benton, Sally C. ;
Butler, Piers ;
Allen, Katy ;
Chesters, Michelle ;
Rickard, Sally ;
Stanley, Sally ;
Roope, Richard ;
Vulkan, Daniel ;
Duffy, Stephen W. .
BRITISH JOURNAL OF CANCER, 2017, 116 (12) :1551-1557
[7]  
Burke W., 2007, Moving beyond ACCE: an expanded framework for genetic test evaluation
[8]   Developing and evaluating polygenic risk prediction models for stratified disease prevention [J].
Chatterjee, Nilanjan ;
Shi, Jianxin ;
Garcia-Closas, Montserrat .
NATURE REVIEWS GENETICS, 2016, 17 (07) :392-406
[9]   'Why don't I need a colonoscopy?' A novel approach to communicating risks and benefits of colorectal cancer screening [J].
Emery, Jon D. ;
Pirotta, Marie ;
Macrae, Finlay ;
Walker, Jennifer G. ;
Qama, Ashleigh ;
Boussioutas, Alex ;
Jenkins, Mark .
AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2018, 47 (06) :343-349
[10]   Can the breast screening appointment be used to provide risk assessment and prevention advice? [J].
Evans, D. Gareth ;
Howell, Anthony .
BREAST CANCER RESEARCH, 2015, 17